Analysis of the commercial, regulatory and infrastructure landscape in China for a Top 10 pharmaceuticals client.
The client requested an all-round analysis on the oncology market landscape in China, including market size, key players, healthcare infrastructure, and especially recent trends in regulatory, market access, and intellectual property rights environment, in order to support planning and strategic decisions in China.
Our Solution
GlobalData leveraged its proprietary China pharma market data, as well as additional secondary research in both English and Chinese, to identify the latest market trends in oncology in China.
GlobalData also performed primary research with stakeholders in China’s regulatory and reimbursement agencies to gather insights regarding the current and future oncology market access situations.
Outcome
GlobalData delivered a robust presentation specific on the oncology market landscape in China, with the latest market trend data that are only available in local language. Innovative visualization was used throughout the report to enhance readability of the presentation.
Our consultants work closely with you to understand requirements and develop a tailored approach and deliverables.
